FindTrial
Sign In

Monitoring biosignals using smart devices in limited environments

Biological Signal Monitoring Using Smart Devices in Patients Using Radiopharmaceuticals: Prospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0009633
Enrollment
100
Registered
2024-07-11
Start date
2024-08-28
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

National Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients aged 19 to 80 years 2. Patients waiting to visit the nuclear medicine department after deciding to administer radiopharmaceuticals 3. Patients who voluntarily decided to participate in this clinical study and signed a written informed consent

Exclusion criteria

Exclusion criteria: 1. Patients with a history of allergy to radiopharmaceuticals 2. Patients with mental illness, those with a history of alcoholism or drug abuse 3. Persons judged by the researcher to be unsuitable to participate in the study for other reasons

Design outcomes

Primary

MeasureTime frame
Collection of vital signs while waiting for patients using radiopharmaceuticals—

Secondary

MeasureTime frame
Establishment of an alarm system based on biosignal collection results and management of collected data—

Countries

Korea, Republic of

Contacts

Public ContactSu Yeon Hwang

National Cancer Center

syhwang@ncc.re.kr+82-31-920-0982

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026